ES2134928T3 - Derivado de benzotiazolsulfonamida, procedimiento de produccion y aplicacion del mismo. - Google Patents

Derivado de benzotiazolsulfonamida, procedimiento de produccion y aplicacion del mismo.

Info

Publication number
ES2134928T3
ES2134928T3 ES94904742T ES94904742T ES2134928T3 ES 2134928 T3 ES2134928 T3 ES 2134928T3 ES 94904742 T ES94904742 T ES 94904742T ES 94904742 T ES94904742 T ES 94904742T ES 2134928 T3 ES2134928 T3 ES 2134928T3
Authority
ES
Spain
Prior art keywords
lower alkyl
represent
same
benzotiazolsulfonamida
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94904742T
Other languages
English (en)
Inventor
Akiro Kajihara
Masahiko Tsuchiya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Industry Co Ltd, Asahi Kasei Kogyo KK filed Critical Asahi Chemical Industry Co Ltd
Application granted granted Critical
Publication of ES2134928T3 publication Critical patent/ES2134928T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN DERIVADO DE BENZOTIAZOLSULFONAMIDAS REPRESENTADO POR LA FORMULA GENERAL (1) Y QUE TIENE LA ACTIVIDAD DE INHIBIR LAS FOSFORILASAS DE PROTEINAS TALES COMO LA QUINASA PROTEINA C Y LA QUINASA MIOSINA DE CADENA LIGERA, UNA SAL DE ADICION ACIDA DEL MISMO ACEPTABLE FARMACEUTICAMENTE, UN PROCESO PARA PRODUCIRLO, UNA COMPOSICION MEDICA QUE CONTIENE EL MISMO, Y UN MEDICAMENTO QUE LO CONTIENE COMO INGREDIENTE ACTIVO PARA TRATAR O PREVENIR EL ASMA SOBRE LA BASE DE LA ACTIVIDAD INHIBIDORA DE LA FOSFORILASA DE PROTEINA. EN LA FORMULA (1) A REPRESENTA UN ALQUILENO INFERIOR; R1 REPRESENTA HIDROGENO O UN ALQUILO INFERIOR; R2 Y R3 REPRESENTAN CADA UNO INDEPENDIENTEMENTE HIDROGENO O ALQUILO INFERIOR, O SE COMBINAN JUNTOS PARA REPRESENTAR UN ALQUILENO INFERIOR; R2 Y R3 REPRESENTAN CADA UNO INDEPENDIENTEMENTE HIDROGENO O ALQUILO INFERIOR, O SE COMBINAN JUNTOS PARA REPRESENTAR UN ALQUILENO INFERIOR; Y R4 REPRESENTA HIDROGENO, ALQUILO INFERIOR, AMIDINO O ALQUIL FENILO INFERIOR, EN DONDE EL GRUPO FENIL ESTA MONOSUSTITUIDO O DISUSTITUIDO POR ALQUIL INFERIOR ALCOXI INFERIOR, HALOGENO O METILENODIOXI.
ES94904742T 1993-02-19 1994-01-20 Derivado de benzotiazolsulfonamida, procedimiento de produccion y aplicacion del mismo. Expired - Lifetime ES2134928T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3000793 1993-02-19

Publications (1)

Publication Number Publication Date
ES2134928T3 true ES2134928T3 (es) 1999-10-16

Family

ID=12291831

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94904742T Expired - Lifetime ES2134928T3 (es) 1993-02-19 1994-01-20 Derivado de benzotiazolsulfonamida, procedimiento de produccion y aplicacion del mismo.

Country Status (7)

Country Link
US (1) US5504098A (es)
EP (1) EP0638564B1 (es)
KR (2) KR950701329A (es)
CA (1) CA2118425C (es)
DE (1) DE69420345T2 (es)
ES (1) ES2134928T3 (es)
WO (1) WO1994019336A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996006088A1 (en) * 1994-08-18 1996-02-29 Asahi Kasei Kogyo Kabushiki Kaisha Benzothiazolesulfonamide derivative having terminal cycloalkyl group and medicinal use thereof
TW513418B (en) * 1996-07-31 2002-12-11 Otsuka Pharma Co Ltd Thiazole derivatives, their production and use
ATE315394T1 (de) 1997-11-10 2006-02-15 Bristol Myers Squibb Co Benzothiazole als protein tyrosin-kinase inhibitoren
KR100384693B1 (ko) * 2000-04-07 2003-05-22 삼성전자주식회사 메트릭스 메탈로프로테이나제의 저해제로서의 설폰아미드유도체
KR100405912B1 (ko) * 2000-04-08 2003-11-14 삼성전자주식회사 메트릭스 메탈로프로테이나제의 저해제로서의 설폰아미드유도체
SE0004780D0 (sv) 2000-12-22 2000-12-22 Jordanian Pharmaceutical Mfg & Novel compunds
FR2833840B1 (fr) * 2001-12-21 2010-06-18 Rytek Methodes et compositions pour le traitement de pathologies respiratoires
KR20040041418A (ko) * 2002-11-11 2004-05-17 재단법인 목암생명공학연구소 설폰아미드계 유도체를 함유하는 혈관신생 억제제
FR2879100B1 (fr) 2004-12-09 2007-07-06 Lionel Bueno Compositions pour le traitement des pathologies oculaires de surface et de la retine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE786520A (fr) * 1971-07-23 1973-01-22 Bayer Ag Nouveaux benzothiazoles substitues, leur preparation et leur application comme fongicides et bactericides
JPH01242574A (ja) * 1988-03-25 1989-09-27 Ube Ind Ltd 含窒素縮合環を有するピペリジン及びピペラジン誘導体、その製造方法並びにそれを含む薬学的組成物
WO1992014712A1 (en) * 1991-02-13 1992-09-03 Asahi Kasei Kogyo Kabushiki Kaisha Substituted sulfonamide derivative or pharmaceutical composition containing the same
ATE188379T1 (de) * 1992-10-14 2000-01-15 Merck & Co Inc Fibrinogenrezeptor-antagonisten

Also Published As

Publication number Publication date
EP0638564B1 (en) 1999-09-01
WO1994019336A1 (fr) 1994-09-01
CA2118425A1 (en) 1994-09-01
KR0134069B1 (ko) 1998-04-22
DE69420345T2 (de) 1999-12-30
EP0638564A4 (en) 1995-04-19
DE69420345D1 (de) 1999-10-07
KR950701329A (ko) 1995-03-23
EP0638564A1 (en) 1995-02-15
US5504098A (en) 1996-04-02
CA2118425C (en) 1997-08-12

Similar Documents

Publication Publication Date Title
MX9701765A (es) Derivado heterociclico y medicina.
BR9814592A (pt) "compostos azopolicìclicos condensados com arila"
ES2149267T3 (es) Carbonilos ciclicos substituidos y derivados de los mismos utiles como inhibidores de la proteasa retroviral.
ES2194501T3 (es) Derivados de amidinas, su preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
TR200102020T2 (tr) Raf kinaz inhibitörleri olarak w-karboksiaril sübstitüe edilmiş difenil üreler.
PA8504401A1 (es) Compuestos farmaceuticamente activos
BR9901491A (pt) 7-hetero-biciclo [2.2.1] - heptanos.
BR0312695A (pt) Derivados de 1h-pirrolidina-2,4-diona espirocìclicos substituìdos por cis-alcóxi
BR0111126A (pt) Derivados de aminoácidos cìclicos úteis como agentes farmacêuticos
ID26956A (id) Pencegahan raf kinase menggunakan simetris dan nonsimetris yang digantikan diphenil urea
DE60132309D1 (de) Amin-derivate zur behandlung von apoptosis
ES2104946T3 (es) Ureas ciclicas y similares utiles como inhibidores de la proteasa retrovirica.
BG100016A (bg) Нiv протеазни инхибитори във фармацевтични комбинации за лечение на спин
ES2108238T3 (es) Derivados de esteres de hexahidronaftaleno, su preparacion y sus utilizaciones terapeuticas.
DE69825048D1 (de) Analoga von duocarmycin and cc-1065
BR0112540A (pt) Peptìdios como inibidores da ns-3-serina protease do vìrus da hepatite c
BR0200782A (pt) Compostos para o tratamento da isquemia
BR0015605A (pt) Composição e uso
BR0012970A (pt) Compostos e composições antipicornavirais, seus usos farmacêuticos e materiais para a sua sìntese
EA200201201A1 (ru) Соединения с сульфамидной группой и содержащие эти соединения фармацевтические композиции
AR013001A1 (es) Derivados de la piperazina, procedimientos para prepararlos, las composiciones farmaceuticas que los contienen, su utilizacion como medicamentoy el metodo para tratar enfermedades mediadas por la taquinina.
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
DK0679393T3 (da) Pharmaceutisk præparat til behandling af osteoporose indeholdende xanthohumol
ES2134928T3 (es) Derivado de benzotiazolsulfonamida, procedimiento de produccion y aplicacion del mismo.
BR0209440A (pt) Sulfonamidas

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 638564

Country of ref document: ES